FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053017816> ?p ?o ?g. }

• W2053017816 endingPage "S23" @default.
• W2053017816 startingPage "S23" @default.
• W2053017816 abstract "Epidemiological studies suggest a role for calcium in prevention of colorectal cancer (CRC). The antiproliferative action of calcium in colon might be mediated by the calcium sensing receptor (CaSR). The CaSR expression is lost in human CRC. We hypothesized that DNA hypermethylation and histone deacetylation may cause CaSR silencing in tumors. We analyzed CaSR mRNA and protein expression in colorectal tumors and cell lines by real time qRT-PCR and immunofluorescence. We determined the methylation pattern in the second promoter of CaSR that contains a large CpG island by bisulfite sequencing. To induce the expression of CaSR we treated four colon tumor cell lines with 5-aza-2-deoxycytidine (5-aza-dC), a DNA methyltransferase inhibitor, and two different histone deacetylase inhibitors (HDIs) suberoylanilide hydroxamic acid and sodium butyrate. In our patient cohortwe observed significantly less CaSRmRNA expression (Pb0.001) in colorectal tumors compared with adjacent mucosa from the same patient. Immunofluorescence staining confirmed downregulation of CaSR protein in tumors. The CaSR promoter was strongly methylated in tumors compared with respective adjacent mucosa and we found a weak, but significant correlation between extent of methylation and mRNA expression (Spearman's rho=−0.29, Pb0.05). Although in cell lines analyzed, CaSR promoter was densely methylated, treatment with 5-aza-dC caused only modest increase of CaSR expression. The HDIs restored the expression of CaSR in a compound and cell line dependent manner. In summary, DNA hypermethylation and histone deacetylation seem to be important players in silencing CaSR expression in colorectal cancer, although additional mechanism or factors might be also involved. doi:10.1016/j.bone.2012.08.077 O59 Involvement of the calcium sensing receptor in colorectal cancer proliferation A. Aggarwal, J. Hobaus, I.Sh. Fetahu, I. Mesteri, Eniko Kallay Department of Pathophysiology and Allergy Research, Medical University Vienna, Austria Department of Pathology, Medical University Vienna, Austria Abstract: Epidemiological studies suggest an inverse correlation between dietary Epidemiological studies suggest an inverse correlation between dietary Calcium intake and colorectal cancer (CRC) risk. During tumourigenesis, expression of the calcium-sensing receptor (CaSR) is diminished probably leading to loss of sensitivity to the tumour inhibiting effects of Calcium in transformed cells. We hypothesized that the CaSR mediates anti-proliferative effects of Calcium. We examined the expression of CaSR and of a cluster of genes regulating replication licensing (CDT1, CDC6, CDC45, MCM2-7, Geminin) at mRNA level by qRT-PCR in CRC samples and respective adjacent mucosa (n=57). To study the effect of Calcium in normal colon physiology, we fed C57BL/6 mice with a diet containing high (0.9%) or low (0.1%) levels of Calcium and assessed the influence of dietary Calcium on proliferation (Ki67 immunohistochemistry staining) and CaSR mRNA expression. In tumours we found significantly less CaSR expression and significantly higher expression of genes involved in replication licensing compared with respective adjacent mucosa (pb0.001). Furthermore, in tumour samples we found negative correlation between CaSR and the licensing factors (CDC45 (pb0.05, ρ=−0.265) and MCM6 (pb0.05, ρ=−0.262) reaching significance). Surprisingly, CaSR showed a positive correlation with the licensing factors in ‘normal’ tissue (CDT1 (pb0.05, ρ=0.269), MCM2 (pb0.003, ρ=0.382) andMCM5 (pb0.001, ρ=0.490)). In vivo we saw that low dietary Calcium enlarged the proliferative zone of the crypts with a parallel increase in CaSR expression. The upregulation of CaSR is probably a defence mechanism of normal colonocytes to control epithelial growth and counteract hyper-proliferative signals. This control mechanism is lost in cancer where the CaSR expression is lost. doi:10.1016/j.bone.2012.08.078 O60 The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis C. Casala, E. Gil-Guinon, J.L. Ordonez, S. Miguel-Queralt, E. Rodriguez, P. Galvan, C. Lavarino, F. Munell, E. de Alava, J. Mora, C. de Torres Developmental Tumor Biology Laboratory, Hospital Sant Joan de Deu, Barcelona, Spain Centro de Investigacion del Cancer-IBMCC (USAL-CIC), Salamanca, Spain Institut de Recerca Hospital Vall d'Hebron, Barcelona, Spain Salamanca University Hospital, Spain Abstract: We have analyzed genetic and epigenetic mechanisms potentially We have analyzed genetic and epigenetic mechanisms potentially responsible for transcriptional silencing of the calcium-sensing receptor (CaSR) in unfavorable neuroblastomas (NB). Hypermethylation of a specific region within the CpG island encompassing the CaSR gene promoter 2 was detected in 25% primary NB, in association with reduced CaSR mRNA expression and several predictors of poor outcome in NB, including amplification of the oncogene MYCN. Hypermethylation of this region was also detected in MYCN-amplified NB cell lines in which the CaSR expression was reduced or absent. Treatment with 5′aza-2-deoxycitidine (Aza) and/or trichostatin A restored the expression of the CaSR in these cell lines and, following Aza exposure, concurrent decreased percentages of methylated CpG sites were observed at the abovementioned region. Also, by interphase fluorescence in situ hybridization, monosomy of chromosome 3, where the human CASR gene resides, was seen in N90% of primary NTs of all clinical, histological and biological subgroups. Furthermore, ectopic overexpression of the CaSR in two MYCN-amplified NB cell lines in which this gene is silenced by promoter hypermethylation significantly reduced their in vitro proliferation rates and almost abolished their capacity to generate xenografts in immunocompromised mice. Finally, upon acute exposure to calcium, CaSR-overexpressing NB cells underwent apoptosis, a process dependent on sustained activation of ERK1/2. These data would support the hypothesis that epigenetic silencing of the CaSR gene is not an in vitro artefact in NB cell lines, nor a passenger event in primary NB, but a mechanism relevant for NB survival. doi:10.1016/j.bone.2012.08.079 O61 Effect of increased dietary calcium on murine colonic CaSR expression and the effect of induced colitis on “rescued” CaSR−/PTH− (C−/P−) knockout mice R. Turki, J.E. Kelly, I. Pacheco, R.J. MacLeod GIDRU/Physiology, DBMS, Queen's University, Canada Pathology and Molecular Medicine, Queen's University, Canada Abstract: Introduction: Increased consumption of milk reduces the risk of colon cancer. Colitis increases risk of developing colon cancer. We determined if the colonic CaSR was altered by increased dietary calcium and characterized the effect of induced colitis in control (C+/P+) and C−/P− knockout mice. Methods: PWK/PhJ and NIHSwiss mice were fed 0.5% (A), 2% calcium (B) or 2% with VitD3 (C) diets for 4 wks. Colitis induced by feeding 3% dextran sodium sulphate (DSS) to C+/P+ and C−/P− mice for 5 days. Myelin peroxidase (MPO) activity and TNFα levels were measured. Abstracts S23 Introduction: Increased consumption of milk reduces the risk of colon cancer. Colitis increases risk of developing colon cancer. We determined if the colonic CaSR was altered by increased dietary calcium and characterized the effect of induced colitis in control (C+/P+) and C−/P− knockout mice. Methods: PWK/PhJ and NIHSwiss mice were fed 0.5% (A), 2% calcium (B) or 2% with VitD3 (C) diets for 4 wks. Colitis induced by feeding 3% dextran sodium sulphate (DSS) to C+/P+ and C−/P− mice for 5 days. Myelin peroxidase (MPO) activity and TNFα levels were measured. Abstracts S23" @default.
• W2053017816 created "2016-06-24" @default.
• W2053017816 creator A5020443009 @default.
• W2053017816 creator A5046330265 @default.
• W2053017816 creator A5046509853 @default.
• W2053017816 creator A5062549231 @default.
• W2053017816 creator A5069579084 @default.
• W2053017816 creator A5076609541 @default.
• W2053017816 creator A5077481159 @default.
• W2053017816 creator A5080045343 @default.
• W2053017816 date "2012-12-01" @default.
• W2053017816 modified "2023-10-17" @default.
• W2053017816 title "Involvement of epigenetic mechanisms in regulating expression of the calcium sensing receptor in colorectal cancer" @default.
• W2053017816 doi "https://doi.org/10.1016/j.bone.2012.08.077" @default.
• W2053017816 hasPublicationYear "2012" @default.
• W2053017816 type Work @default.
• W2053017816 sameAs 2053017816 @default.
• W2053017816 citedByCount "0" @default.
• W2053017816 crossrefType "journal-article" @default.
• W2053017816 hasAuthorship W2053017816A5020443009 @default.
• W2053017816 hasAuthorship W2053017816A5046330265 @default.
• W2053017816 hasAuthorship W2053017816A5046509853 @default.
• W2053017816 hasAuthorship W2053017816A5062549231 @default.
• W2053017816 hasAuthorship W2053017816A5069579084 @default.
• W2053017816 hasAuthorship W2053017816A5076609541 @default.
• W2053017816 hasAuthorship W2053017816A5077481159 @default.
• W2053017816 hasAuthorship W2053017816A5080045343 @default.
• W2053017816 hasConcept C104317684 @default.
• W2053017816 hasConcept C121608353 @default.
• W2053017816 hasConcept C126322002 @default.
• W2053017816 hasConcept C142590548 @default.
• W2053017816 hasConcept C143998085 @default.
• W2053017816 hasConcept C199360897 @default.
• W2053017816 hasConcept C41008148 @default.
• W2053017816 hasConcept C41091548 @default.
• W2053017816 hasConcept C502942594 @default.
• W2053017816 hasConcept C519063684 @default.
• W2053017816 hasConcept C526805850 @default.
• W2053017816 hasConcept C54355233 @default.
• W2053017816 hasConcept C71924100 @default.
• W2053017816 hasConcept C86803240 @default.
• W2053017816 hasConcept C87975464 @default.
• W2053017816 hasConcept C90559484 @default.
• W2053017816 hasConceptScore W2053017816C104317684 @default.
• W2053017816 hasConceptScore W2053017816C121608353 @default.
• W2053017816 hasConceptScore W2053017816C126322002 @default.
• W2053017816 hasConceptScore W2053017816C142590548 @default.
• W2053017816 hasConceptScore W2053017816C143998085 @default.
• W2053017816 hasConceptScore W2053017816C199360897 @default.
• W2053017816 hasConceptScore W2053017816C41008148 @default.
• W2053017816 hasConceptScore W2053017816C41091548 @default.
• W2053017816 hasConceptScore W2053017816C502942594 @default.
• W2053017816 hasConceptScore W2053017816C519063684 @default.
• W2053017816 hasConceptScore W2053017816C526805850 @default.
• W2053017816 hasConceptScore W2053017816C54355233 @default.
• W2053017816 hasConceptScore W2053017816C71924100 @default.
• W2053017816 hasConceptScore W2053017816C86803240 @default.
• W2053017816 hasConceptScore W2053017816C87975464 @default.
• W2053017816 hasConceptScore W2053017816C90559484 @default.
• W2053017816 hasIssue "6" @default.
• W2053017816 hasLocation W20530178161 @default.
• W2053017816 hasOpenAccess W2053017816 @default.
• W2053017816 hasPrimaryLocation W20530178161 @default.
• W2053017816 hasRelatedWork W152563574 @default.
• W2053017816 hasRelatedWork W1984432242 @default.
• W2053017816 hasRelatedWork W1984893191 @default.
• W2053017816 hasRelatedWork W2044401234 @default.
• W2053017816 hasRelatedWork W2075214100 @default.
• W2053017816 hasRelatedWork W2364051953 @default.
• W2053017816 hasRelatedWork W2388808113 @default.
• W2053017816 hasRelatedWork W2392730113 @default.
• W2053017816 hasRelatedWork W3004259476 @default.
• W2053017816 hasRelatedWork W4309211534 @default.
• W2053017816 hasVolume "51" @default.
• W2053017816 isParatext "false" @default.
• W2053017816 isRetracted "false" @default.
• W2053017816 magId "2053017816" @default.
• W2053017816 workType "article" @default.